These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 14249261)

  • 21. INTERFERENCE BETWEEN POLIOVIRUSES AND THE EFFECT OF ULTRA-VIOLET LIGHT.
    FENWICK ML
    Nature; 1963 Dec; 200():1129. PubMed ID: 14098467
    [No Abstract]   [Full Text] [Related]  

  • 22. PREVENTION OF POLIOMYELITIS IN SINGAPORE BY LIVE VACCINE.
    LEE LH; LIM KA; TYE CY
    Br Med J; 1964 Apr; 1(5390):1077-80. PubMed ID: 14113821
    [No Abstract]   [Full Text] [Related]  

  • 23. A NATIONWIDE SERUM SURVEY OF UNITED STATES MILITARY RECRUITS, 1962. II. POLIOVIRUS ANTIBODY LEVELS.
    NIEDERMAN JC; OPTON EM
    Am J Hyg; 1964 Nov; 80():293-303. PubMed ID: 14225919
    [No Abstract]   [Full Text] [Related]  

  • 24. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 25. A SERUM INHIBITOR IN ANIMAL AND HUMAN SERA OF BOVINE ENTEROVIRUSES. II. IN VIVO ACTIVITY AND ROLE IN "NATURAL" RESISTANCE TO INFECTION.
    KLEIN M; DEFOREST A
    J Immunol; 1964 May; 92():822-6. PubMed ID: 14170425
    [No Abstract]   [Full Text] [Related]  

  • 26. SPECIFIC VIRUS-NEUTRALIZING ACTIVITY OF SERA FROM CHICKS IMMUNIZED WITH POLIOVIRUSES.
    SLONIM D; DREVO M
    Acta Virol; 1963 Nov; 7():504-15. PubMed ID: 14098065
    [No Abstract]   [Full Text] [Related]  

  • 27. [ON THE DETERMINATION OF THE NEUROVIRULENCE OF LIVE POLIOVIRUS VACCINES. II. PATHOMORPHOLOGY OF APE POLIOMYELITIS CAUSED BY ATTENUATED POLIOVIRUSES AFTER INTRALUMBAR INJECTION WITH SPECIAL REFERENCE TO DIFFERENCES BETWEEN THE VIRUS TYPES].
    UNTERHARNSCHEIDT F; BONIN O
    Arch Psychiatr Nervenkr; 1965 Mar; 206():454-73. PubMed ID: 14271779
    [No Abstract]   [Full Text] [Related]  

  • 28. DEXTRAN SULFATE PLAQUE VARIANTS OF ATTENUATED TYPE 1 POLIOVIRUS. RELATIONSHIP TO IN VITRO AND IN VIVO MARKERS.
    TAKEMOTO KK; KIRSCHSTEIN RL
    J Immunol; 1964 Feb; 92():329-33. PubMed ID: 14160455
    [No Abstract]   [Full Text] [Related]  

  • 29. REACTION OF POLIOVIRUS AND FORMALDEHYDE IN MAGNESIUM CHLORIDE SOLUTION TO ENHANCE POTENCY OF KILLED-VIRUS VACCINE.
    OZAKI Y; MELNICK JL
    J Immunol; 1963 Mar; 90():429-37. PubMed ID: 14051877
    [No Abstract]   [Full Text] [Related]  

  • 30. POLIOMYELITIS IN DUNDEE, 1962.
    WEIR IB; JAMIESON WM; GREEN DM
    Br Med J; 1964 Oct; 2(5413):853-7. PubMed ID: 14185637
    [No Abstract]   [Full Text] [Related]  

  • 31. [RESEARCH "IN VITRO" ON THE ANTIPOLIOMYELITIC ACTIVITY OF GUANIDINE AND ON ITS CAPACITY TO INDURE A GUANIDINE-DEPENDENCE OF THE VIRUS].
    BROTZU G; FERRARI W; LODDO B; SPANEDDA A
    G Ital Chemioter; 1963; 10():1-23. PubMed ID: 14079388
    [No Abstract]   [Full Text] [Related]  

  • 32. GENOMIC MASKING PRODUCED BY DOUBLE-INFECTION OF HELA CELLS WITH HETEROTYPIC POLIOVIRUSES.
    WECKER E; LEDERHILGER G
    Proc Natl Acad Sci U S A; 1964 Sep; 52(3):705-9. PubMed ID: 14212545
    [No Abstract]   [Full Text] [Related]  

  • 33. [DETECTION OF ANTIBODIES TO MONKEY VIRUS (OB40) IN HUMAN SERA. SEROLOGICAL EVIDENCE OF INFECTION FROM MONKEYS AND KIDNEY CULTURES].
    CHUMAKOVA MIa; CHUMAKOV MP; ELBERT LB; AVGUSTINOVICH GI; RALF NM; VOROSHILOVA MK; TARANOVA GP; TAPUPERE VO
    Vopr Virusol; 1963; 29():457-60. PubMed ID: 14071285
    [No Abstract]   [Full Text] [Related]  

  • 34. [ON THE EFFECT OF DEXTRAN SULFATE ON SABIN ORAL POLIOMYELITIS VACCINAL STRAINS].
    VOSS H
    Z Naturforsch B; 1964 Mar; 19():226-9. PubMed ID: 14175997
    [No Abstract]   [Full Text] [Related]  

  • 35. [WHAT DOES THE TESTING OF VIRAL VACCINES DO FOR THE HARMLESSNESS OF VACCINES IN THEIR PRACTICAL USE?].
    BONIN O; GUENTHER O
    Med Welt; 1964 Apr; 15():822-31. PubMed ID: 14194499
    [No Abstract]   [Full Text] [Related]  

  • 36. STUDY OF INTRATYPIC DIFFERENCES BETWEEN 2 POLIOVIRUSES. I. RELATIONSHIP BETWEEN NEUROVIRULENCE, ANTIGENICITY AND OTHER PROPERTIES DETERMINED ON CELLS IN VITRO.
    BALAYAN MS; TOLSKAYA EA; VOROSHILOVA MK; YUROVETSKAYA AL
    Virology; 1964 Jun; 23():125-40. PubMed ID: 14187900
    [No Abstract]   [Full Text] [Related]  

  • 37. INTERNATIONAL STANDARDS FOR ANTI-POLIOVIRUS SERA TYPES 1, 2 AND 3.
    LYNG J; BENTZON MW
    Bull World Health Organ; 1963; 29(6):711-20. PubMed ID: 14107743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further studies on the kinetic serum-neutralization (McBride) test for polioviruses.
    Furesz J; Armstrong RE
    Can J Microbiol; 1967 Sep; 13(9):1223-33. PubMed ID: 4293355
    [No Abstract]   [Full Text] [Related]  

  • 39. INFECTIOUS RNA SYNTHESIZED IN MONKEY KIDNEY TISSUE CULTURE CELLS INFECTED WITH POLIOVIRUS.
    ENGLER R; TOLBERT O
    Virology; 1965 Jun; 26():246-52. PubMed ID: 14323992
    [No Abstract]   [Full Text] [Related]  

  • 40. Intratypic serodifferentiation of polioviruses by comparison of neutralization indices and correlation of the antigenic marker, temperature marker and monkey neurovirulence.
    Smit GL; Wilterdink JB
    Arch Gesamte Virusforsch; 1966; 18(3):261-75. PubMed ID: 4295526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.